Brady Corp: Form 10-Q for the period ended Apr 30, 2022
Filed with the SEC on May 26, 2022 and accepted by EDGAR at May 26, 2022, 07:21 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-04-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-02-01 to 2022-04-30 | $338.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2021-08-01 to 2022-04-30 | $978.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-02-01 to 2022-04-30 | $174.5m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2021-08-01 to 2022-04-30 | $509.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-02-01 to 2022-04-30 | $164.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2021-08-01 to 2022-04-30 | $468.4m | us-gaap:GrossProfit |
| Research and development | 3 months2022-02-01 to 2022-04-30 | $14.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2021-08-01 to 2022-04-30 | $42.8m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-02-01 to 2022-04-30 | $96.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2021-08-01 to 2022-04-30 | $285.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-02-01 to 2022-04-30 | $52.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-08-01 to 2022-04-30 | $140.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-02-01 to 2022-04-30 | $329.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2021-08-01 to 2022-04-30 | $763.0k | us-gaap:InterestExpense |
| Income tax | 3 months2022-02-01 to 2022-04-30 | $11.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2021-08-01 to 2022-04-30 | $29.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-02-01 to 2022-04-30 | $40.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months2021-08-01 to 2022-04-30 | $108.9m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months2022-02-01 to 2022-04-30 | 51,568,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2021-08-01 to 2022-04-30 | 52,055,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2021-08-01 to 2022-04-30 | $65.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2021-08-01 to 2022-04-30 | $22.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2021-08-01 to 2022-04-30 | $34.7m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2021-08-01 to 2022-04-30 | $84.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-04-30 | $103.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-04-30 | $479.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-04-30 | $1.34bn | us-gaap:Assets |
| Current liabilities | At period end2022-04-30 | $243.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-04-30 | $430.0m | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-04-30 | $914.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000746598-22-000044. Last ingested by Listed: Nov 9, 2026, 17:29 ET. Listed shows no prices and gives no investment advice.